Pandemic sustaining the portfolio
31/07/20 -"Clariant did quite well in the pandemic as speciality chemicals have offerings to help manage the crisis better. This does not necessarily mean they are “bullet proof” chemicals but their ..."
Pages
51
Language
English
Published on
31/07/20
You may also be interested by these reports :
12/11/26
Brenntag’s CMD introduced a new medium-term framework targeting growth above the chemical market, a ~10% operating EBITDA margin and ROIC above 12%. ...
11/11/26
Brenntag’s Q3 sales beat consensus by 6.6%, supported by higher chemical prices and favourable FX. However, operating EBITDA was broadly in line with ...
11/11/26
1Q26/27: All in all, a solid start – FY26/27E guidance confirmed
10/11/26
K+S’s Q3 2026 sales growth was driven by price and mix, not volume, as the Bethune shutdown hit volumes. De-icing refill demand lifted Industry+. ...